Andrew Lewin

Summary

Publications

  1. pmc Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age
    Andrew J Lewin
    National Research Institute, 2010 Wilshire Blvd Ste 302, Los Angeles, CA, 90057, USA
    Drugs Aging 30:549-60. 2013
  2. doi request reprint Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial
    Andrew Lewin
    National Research Institute, Los Angeles, CA 90057, USA
    Clin Ther 35:142-52. 2013
  3. doi request reprint Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trial
    Andrew J Lewin
    National Research Institute, Los Angeles, California 90057, USA
    Clin Ther 34:1909-19.e15. 2012
  4. doi request reprint Nebivolol withdrawal results in blood pressure returning toward pretreatment levels, but without rebound symptoms: phase IV randomized trial
    Andrew Lewin
    National Research Institute, Los Angeles, CA 90057, USA
    J Am Soc Hypertens 6:228-36. 2012

Detail Information

Publications4

  1. pmc Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age
    Andrew J Lewin
    National Research Institute, 2010 Wilshire Blvd Ste 302, Los Angeles, CA, 90057, USA
    Drugs Aging 30:549-60. 2013
    ..Hypertension is often inadequately controlled in older people...
  2. doi request reprint Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial
    Andrew Lewin
    National Research Institute, Los Angeles, CA 90057, USA
    Clin Ther 35:142-52. 2013
    ..Elevated systolic blood pressure (SBP) is an independent risk factor for cardiovascular events and mortality...
  3. doi request reprint Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trial
    Andrew J Lewin
    National Research Institute, Los Angeles, California 90057, USA
    Clin Ther 34:1909-19.e15. 2012
    ..This study was designed to assess the utility of adjunctive therapy with the dipeptidyl peptidase (DPP)-4 inhibitor linagliptin in patients with T2DM inadequately controlled with SU monotherapy...
  4. doi request reprint Nebivolol withdrawal results in blood pressure returning toward pretreatment levels, but without rebound symptoms: phase IV randomized trial
    Andrew Lewin
    National Research Institute, Los Angeles, CA 90057, USA
    J Am Soc Hypertens 6:228-36. 2012
    ..Nebivolol withdrawal resulted in a mean BP increase near pretreatment levels and was not associated with rebound hypertension...